The role of insulin in the regulation of brain dopaminergic activity was proposed a decade ago, since the identification of elevated levels of IGF-1 and IGF binding proteins (IGFBPs) in the serum and cerebrospinal fluid (CSF) of patients with PD [65]. Here, INS is linked to Parkinson disease.